Immunological typing of acute lymphoblastic leukaemia. 1983

H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne

The blasts of 37 adult and 126 childhood cases of acute lymphoblastic leukaemia (ALL) were characterized with a panel of xeno-antisera and rosette tests. The Orthoclone monoclonal antibodies (OK series) were applied as well. Like other investigators, we were able to distinguish 4 major classes of ALL: T-ALL, common-ALL with the subclass pre-B-ALL, null-ALL, and B-ALL. We did not encounter a common-ALL antigen-positive T-ALL subclass. In both adult and childhood ALL, all classes were present, and in about the same frequency as reported by others. In children, common-ALL was the most frequent (66%); in adults, null-ALL (38%). T-ALL was seen both in adults and in children with about the same frequency (27 and 23%, respectively). We found pre-B-ALL only in children. Patients with B-ALL comprised the smallest group in both adult and children (8 and 1.5%, respectively). The application of the OKT antibodies led to recognition of 3 major subclasses of T-ALL: an immature, a common thymocyte and a mature thymocyte subclass. These antibodies were helpful in defining a better classification of null-ALL. With regard to remission induction and prognosis in adult ALL, complete remissions were always obtained in T-ALL, followed by 70% of complete remissions in common-ALL. The worst prognosis was encountered in null-ALL and B-ALL, with 50 and 0% remission, respectively, and a shorter survival in null-ALL of those patients who achieved complete remission. Thus, in high number of cases of null-ALL in adults partly explains the generally much worse prognosis for adult ALL.

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
July 1984, Annals of the Academy of Medicine, Singapore,
H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
January 1976, Haematologia,
H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
January 1989, Leukemia research,
H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
July 1980, Clinical and experimental immunology,
H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
March 2002, Best practice & research. Clinical haematology,
H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
February 2006, La Revue du praticien,
H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
January 1981, Leukemia research,
H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
January 1983, Leukemia research,
H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
February 1977, Nursing mirror and midwives journal,
H J van der Reijden, and E R van Wering, and J M van de Rijn, and C J Melief, and M B van 't Veer, and H Behrendt, and A E von dem Borne
September 2001, Best practice & research. Clinical haematology,
Copied contents to your clipboard!